Kailix Advisors LLC Has $9.97 Million Position in Amrize Ltd $AMRZ

Kailix Advisors LLC increased its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 50.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 205,450 shares of the company’s stock after purchasing an additional 68,870 shares during the period. Amrize accounts for 13.6% of Kailix Advisors LLC’s holdings, making the stock its 5th biggest holding. Kailix Advisors LLC’s holdings in Amrize were worth $9,970,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Public Sector Pension Investment Board lifted its holdings in Amrize by 8.8% during the third quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock worth $14,811,000 after buying an additional 24,738 shares during the period. Cibc World Market Inc. purchased a new stake in shares of Amrize during the 3rd quarter worth $423,000. Rhumbline Advisers purchased a new stake in shares of Amrize during the 3rd quarter worth $935,000. Baader Bank Aktiengesellschaft bought a new stake in Amrize during the third quarter valued at about $1,426,000. Finally, Costello Asset Management INC purchased a new position in Amrize in the third quarter valued at about $44,000.

Insider Activity

In other news, Director Nicholas C. Gangestad bought 2,000 shares of Amrize stock in a transaction that occurred on Wednesday, November 19th. The stock was bought at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the purchase, the director directly owned 4,958 shares of the company’s stock, valued at approximately $234,711.72. The trade was a 67.61% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Kepler Capital Markets raised shares of Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. Morgan Stanley set a $61.00 target price on shares of Amrize and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and increased their price objective for the company from $56.00 to $60.00 in a report on Monday, December 8th. Finally, Wells Fargo & Company boosted their target price on Amrize from $58.00 to $59.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $60.75.

Amrize Trading Up 0.8%

Shares of Amrize stock opened at $58.86 on Friday. The firm’s 50 day simple moving average is $55.38 and its two-hundred day simple moving average is $52.12. The firm has a market capitalization of $32.55 billion and a price-to-earnings ratio of 31.99. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $60.57. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.